Journal
CHEMISTRYSELECT
Volume 1, Issue 8, Pages 1602-1606Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/slct.201600240
Keywords
-
Categories
Funding
- NSERC of Canada (Discovery Grant)
- NSERC of Canada (CREATE)
- NSERC of Canada (USRA)
- CFI (John R. Evans Leaders Fund)
- CIHR
- Workers' Compensation Board of Alberta
- University of Calgary's Eyes High Postdoctoral program
Ask authors/readers for more resources
We present the use of maltol (3-hydroxy-2-methyl-4H-pyran-4one) as a capping ligand for iron oxide nanomaterials. Watersoluble maltol-coated Fe3O4 nanoparticles were synthesized by a reductive one-pot synthesis. The nanoparticles were found to be stable in water, and their superparamagnetic properties enabled their application as ultrahigh field T-2 magnetic resonance imaging (MRI) contrast agents. High r(2) relaxivity and r(2)/r(1) ratios were determined at clinical (B-0 = 3 T) and ultrahigh (B-0 = 9.4 T) fields, making them on par or superior to current iron-oxide based commercial MRI contrast agents. A low cytotoxic re-sponse in three distinct cell types (HUVEC, KB, U343) indicate maltol-coated Fe3O4 nanoparticles are promising T-2 MRI contrast agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available